Newly rising information recommend the Pfizer-BioNTech Covid vaccine works considerably much less nicely at stopping an infection and hospitalizations in kids aged 5 to 11 than it does in these aged 12 to 17 — a discovering that’s elevating questions on whether or not the businesses selected the unsuitable dose for the youthful kids.
The info, from New York state, present a fast and substantial decline in safety after vaccination in kids within the youthful age group, with efficacy towards infections dropping off extra shortly and dramatically than the declines seen in kids aged 12 to 17. The examine additionally discovered a major, however much less steep, decline in safety towards hospitalizations.
The findings, compiled by researchers working for the New York State Division of Well being, had been posted Monday on a preprint server; the examine has not but undergone peer evaluate.
commercial
The New York findings, together with information from a number of different databases, had been lately offered to the Covid vaccine work group of the Advisory Committee on Immunization Practices, impartial vaccine specialists who advise the Facilities for Illness Management and Prevention, sources informed STAT.
The info come on the heels of disappointing outcomes from Pfizer trials of a good decrease vaccine dose in kids below the age of 5. And they’re going to elevate questions on whether or not, in looking for doses that had been each protecting and tolerable in kids, the businesses did not hit the mark for each age teams.
commercial
Pfizer wouldn’t say whether it is exploring the chance that the dose utilized in kids may be too low, however stated it’s “assured within the safety and security” of its Covid-19 vaccine.
“Our updates earlier this 12 months on pursuing a 3-dose schedule for the pediatric inhabitants had been knowledgeable by the effectiveness information for 3 doses of the vaccine for folks 16 years and older, and the early laboratory information noticed with Delta and different variants of concern, together with Omicron, which recommend that individuals vaccinated with three doses of a Covid-19 vaccine might have the next diploma of safety,” it stated in an emailed assertion.
However John Moore, a virologist at Weill Cornell Medical Faculty, stated given the findings of this examine, it’s laborious to see how the decrease efficacy in kids aged 5 to 11 might be on account of something however the decrease dose they acquired. Within the examine, kids aged 12 had the very best vaccine efficacy of all age teams in each cohorts.“The hanging distinction between 11- and 12-year-olds can solely be defined by the three-fold dosing discount within the youthful kids. The one-year age distinction is very unlikely to make some other issue related,” Moore stated by electronic mail. “The 11-year-olds received the 3-fold diminished dose, the 12-year-olds the usual dose.”
The New York examine analyzed well being data for Covid instances in kids and youths from Dec. 13, 2021 to Jan. 30, 2022, a interval throughout which the Omicron variant was quick changing all different types of the SARS-CoV-2 virus within the nation. Covid vaccines will not be as protecting towards Omicron as they had been towards earlier variations of the virus, particularly with out a booster shot.
The state recorded greater than 850,000 Covid instances in adolescents aged 12 to 17 throughout that point, and about 365,000 in kids aged 5 to 11.
Over that interval, two-dose vaccine safety towards an infection for youths aged 5 to 11 declined from 68% to 12%; the vaccine’s effectiveness at stopping hospitalization declined from 100% to 48%.
However two-dose safety towards an infection for kids aged 12 to 17 solely dropped from 66% to 51%, and safety towards hospitalization from 85% to 73%.
“Our information assist vaccine safety towards extreme illness amongst kids 5-11 years, however recommend fast lack of safety towards an infection, within the Omicron variant period,” the researchers wrote. “Ought to such findings be replicated in different settings, evaluate of the dosing schedule for kids 5-11 years seems prudent.”
The grownup Pfizer routine — utilized in anybody aged 12 and older — is 2 doses of 30 micrograms apiece, given 21 days aside. Youngsters 5 to 11 years outdated obtain a dose that’s one-third that measurement, two doses of 10 micrograms apiece. And in research of youngsters below 5, the dose is additional diminished, with the youngsters aged 6 months to 4 years getting two 3-microgram doses. The vaccine just isn’t but licensed to be used in kids below 5.
In December, Pfizer introduced that two doses of the vaccine in kids below 5 had not generated the identical stage of antibodies as was seen after two doses in folks 16 to 25, which was getting used as a proxy for defense. It stated it might give the youngsters below 5 a 3rd dose to see if that achieved the required stage of safety.
However then as Omicron instances spiked throughout the nation, the Meals and Drug Administration revealed it was contemplating a rolling authorization for the vaccine for kids below age 5, permitting mother and father to begin vaccinating their kids whereas ready for the third dose. The rationale was that the risk-benefit equation had shifted with Omicron.
A gathering of the FDA’s vaccine advisers, the Vaccines and Associated Organic Merchandise Advisory Committee, was scheduled for mid-February. However earlier than the group might meet the FDA and Pfizer introduced the plan was on maintain. The plan is now to attend for the third-dose outcomes earlier than contemplating authorization on this age group.
